The standard approach for most politicians in DC is to sit back and tell Americans how to solve healthcare. Georgia congresswoman Marjorie Taylor Greene, for some reason, decided to opt out of it altogether and then jet to Mexico to explain why.
Greene and her fiancé, right-wing media personality Brian Glenn, went to Mexico on June 6 and received intravenous stem cell therapy at Dream Body Clinic in Puerto Vallarta.
The Food and Drug Administration has not approved most stem cell therapies because they have not gone through the process of proving they are safe and effective, which Greene acknowledged directly as the reason the trip happened at all.
Before the trip, Greene posted on X that she was “52 years old,” adding that she has “always eaten well, exercised,” and does not have health insurance. For her, the focus is on “how am I spending money on my health,” and she considers treatments like “stem cell therapies” to be “a great expenditure.”
She also pointed out that “this is a treatment you can’t get in the United States,” explaining that “our FDA does not approve it.”
Calling the situation “really a shame,” she highlighted the cost of healthcare, stating that “Americans spend anywhere from up to $27,000 a year for a family of four for health insurance.”
The Georgia congresswoman concluded that “health insurance is absurdly expensive,” which is why many people are choosing to go outside the traditional healthcare system to better care for their health.
The FDA takes a firmer stance. Citing claims about stem cells online that falsely suggest they can be used for a variety of treatments, agency officials note that the only FDA-approved stem cells sold in the United States are the blood-forming stem cells from umbilical cord blood. They are used to treat a few blood production disorders and conditions, not anti-aging or wellness purposes.
Internet Reacts to Georgia’s Marjorie Taylor Greene Going to Mexico for Stem Cell Therapy
The announcement sparked debate online.
“You have lifetime medical as part of your Congressional retirement package,” one commenter pointed out. Another questioned the financial logic more bluntly: “The woman who made millions off of insider stock trading and bought property in Costa Rica cannot afford health insurance?”
A third took aim at the medical angle: “Nobody needs stem cell therapy if you don’t have blood cancer or some rare autoimmune disease. This is just unscientific bs.” Some pushed back on the relatability framing: “Most common folk aren’t traveling abroad for medical care. You’re not in touch with people.”
According to a Gallup poll (Health-Gup Healthcare in America survey), the percentage of Americans having trouble affording health care is the highest it has been in five years, with 51% of Americans reporting they have difficulty consistently affording health care.
Between 2024 and 2025, the number of Americans reporting difficulties affording health care increased by about 2.8 million people who fall from “cost secure.”
Mercer’s National Survey of Employer-Sponsored Health Plans predicts that employers’ costs for health benefits will increase by 6.5% in 2026, and employees’ paycheck deduction costs for health care are projected to increase by 6-7%. A 6.5% cost increase is a 15-year high (since 2010).
